FindTrial
Sign In

To Optimize time and therapeutic range in AF Patients

TO ASSESS THE BARRIERS OF ANTI-COAGULATION AND OPTIMIZE TIME IN THERAPEUTIC RANGE IN PATIENTS WITH ATRIAL FIBRILLATION AND VALVE REPLACEMENT/REPAIR USING AN APPLICATION BASED ALGORITHM IN TELANGANA, INDIA. - ASSURE INR STUDY

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025537
Enrollment
150
Registered
2020-06-02
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I349- Nonrheumatic mitral valve disorder, unspecified Health Condition 2: I489- Unspecified atrial fibrillation and atrial flutter

Interventions

Intervention1: PHONE BASED APPLICATION: APPLICATION USING NOVAL ALGORITHM TO MONITOR AND OPTIMIZE INR Control Intervention1: conventional INR Monitoring: 6 months

Sponsors

AIG HOSPITAL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients greater than 18 years Patients with Atrial Fibrillation and/or Valve Replacement on Vitamin K antagonists

Exclusion criteria

Exclusion criteria: Patients with multiple thromoembolic/bleeding episodes Patients using NOACs Patients using AC for other indications other than AF/Valve Replacement

Design outcomes

Primary

MeasureTime frame
To compare the Time in Therapeutic Range before and after usage of App in the same cohort of patientsTimepoint: 6 months—

Secondary

MeasureTime frame
To compare the incidence of major bleeding and thromboembolic events before and after the implementation of the INR-ASSIST APP. Number of appropriate Red Alerts received by the patientTimepoint: 6 months—

Countries

India

Contacts

Public ContactDR CALAMBUR NARASIMHAN

AIG Hospital

calambur1@gmail.com9618528340

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026